Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cancer. 2018 Feb 1;124(9):2018–2025. doi: 10.1002/cncr.31269
Model Comparison Breast Prostate Lung Colon
Elixhauser vs. Charlson – individual comorbidiites 0.0284 0.0114 0.0462 0.0424
Cancer-specific Elixhauser vs. generic Elixhauser comorbidity score 0.0027 0.8752 0.8878 0.5317
Cancer-specific Elixhauser vs. generic Charlson comorbidity score 0.0100 0.0323 0.4416 0.0341
Cancer-specific Elixhauser vs. NCI combined index 0.0037 0.2817 0.7018 0.1525
Generic Charlson comorbidity score vs. NCI combined index 0.7399 0.0349 0.5210 0.1606